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Abstract
The COMT and DBH genes are physically located at chromosomes 22q11 and 9q34, respectively,
and both COMT and DBH are involved in catecholamine metabolism and are strong candidates for
certain psychiatric and neurological disorders. Although the genetic determinants for both
enzymes' activities have been widely studied, their genetic involvement on gene mRNA expression
levels remains unclear. In this study we performed quantitative linkage analysis of COMT and DBH
cDNA expression levels, identifying transcriptional regulatory regions for both genes. Multiple
Haseman-Elston regression was used to detect both additive and interactive effects between two
loci. We found that the master transcriptional regulatory region 20q13 had an additive effect on
the COMT expression level. We also found that chromosome 19p13 showed both additive and
interactive effects with 9q34 on DBH expression level. Furthermore, a potential interaction
between COMT and DBH was indicated.
Background
Catechol-O-methyltransferase (COMT) (MIM 116790)
catalyzes the transfer of a methyl group from S-adenosyl-
methionine to catecholamines [1], and dopamine-beta-
hydroxylase (DBH) (MIM 223360) catalyzes the conver-
sion of dopamine to norepinephrine [2]; both enzymes
are involved in the catecholamine metabolism system, in
which abnormalities are hypothesized to be related to the
development of psychiatric and neurological disorders
such as schizophrenia and depression (for reviews, see
[3,4]). There are two distinct forms of COMT, a mem-
brane-bound COMT (MB-COMT) and a soluble COMT
(S-COMT) found in the cell cytoplasm [5]; the former is
predominantly expressed in brain neurons, whereas the
latter is predominantly expressed in other tissues such as
liver and kidney. DBH is expressed in the vesicles of cen-
tral noradrenergic and adrenergic neurons, peripheral
noradrenergic neurons, and adrenomedullary neuron-
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cally located at chromosomes 22q11 and 9q34,
respectively [7,8].
There has been intensive research on the genetic determi-
nants of plasma COMT and DBH activities, and findings
so far strongly suggest that the structural genes COMT and
DBH encoding these proteins are the major quantitative
trait loci for their respective plasma activities; moreover,
in both genes single-nucleotide polymorphisms (SNPs)
have been identified that may account for most of the var-
iation in the enzyme activity levels. On the common func-
tional SNP rs165688, a G→A substitution in exon 4 of
COMT produces a valine→methionine (Val/Met) substi-
tution at codons 158 and 108 in the MB-COMT and S-
COMT transcripts, respectively. This polymorphism has
been shown to have a functional effect on enzyme activity;
in particular, Val is a predominant factor that determines
higher COMT activity [9]. The SNP rs1611115 (-
1021C→T) located in the 5' flanking region of the DBH
gene accounts for 35% to 52% of the variance in plasma
DBH activity in populations from diverse geographic ori-
gins [10].
Though the major effects of these common variants on
enzyme activities have been replicated in independent
samples, their effects on gene mRNA expression levels
remain unclear. The effect of SNP rs165688 on COMT
mRNA expression level has been controversial. Bray et al.
[11] showed that it altered the COMT mRNA expression
level; in contrast, several other studies failed to detect this
association between COMT genotypes and expression
level (for examples, see [12]). So far, studies on the deter-
minants of COMT expression level have been limited to
seeking cis-acting regulators, including SNP rs165688 and
several other SNPs within COMT. To our knowledge,
there is as yet no literature documenting effects of SNPs
on DBH mRNA expression levels.
Phenotypic variation in the transcript level represents an
intermediate stage between DNA sequence differences
and the clinical expression of complex traits, and there
have been studies suggesting a genetic contribution to the
variation in gene expression level [13-15]. In the current
study, we performed quantitative linkage analysis for both
COMT and DBH expression phenotypes, identifying tran-
scriptional regulatory regions for both genes. For COMT,
we first identified cis-acting influences on the gene expres-
sion level, and then we performed a genome-wide linkage
scan for trans-acting regulators across the genome condi-
tional on the cis-acting effect at chromosome 22q11. For
DBH, we similarly first identified the cis-acting influences
on the gene expression level, and then, both conditional
and unconditional on the cis-acting effect at chromosome
9q34, performed a linkage scan for trans-acting regulators
specifically on chromosome 19, based on the evidence
from previous linkage studies [16-18] that there might be
a second locus near chromosome 19p13 acting jointly
with DBH at chromosome 9q34 to influence DBH plasma
activity.
Methods
The study subjects consisted of 14 three-generation CEPH
(Centre d'Etude du Polymorphisme Humain) Utah pedi-
grees, including 371 full sibling pairs. 2,820 SNPs were
relatively evenly genotyped across the 22 autosomes by
the SNP Consortium [19]. Treating the expression level of
COMT and DBH in lymphoblastoid cells of the above
subjects as a quantitative trait, we applied Haseman-
Elston regression model-free linkage analyses [20,21], as
implemented in the SIBPAL program. In particular, only
data on sib pairs were considered (thus avoiding the com-
plication of possible intergenerational heterogeneity) and
the generalized estimating equation technique [22] was
utilized to allow for non-independence of sib pairs within
a sibship. The basic Haseman-Elston (HE) regression can
be written in the form
where Y is a function of traits for a sib pair,  is the esti-
mated proportion of alleles shared identically by descent
(IBD) at marker locus i between members of a sib pair, β0
is the intercept, and β1, the slope, is the locus-specific
genetic variance of the trait attenuated by recombination
between the trait and marker loci. To detect trans-acting
effects at other genomic regions conditional on the cis-act-
ing effect at the structural gene loci (22q11 and 9q34 for
COMT and DBH, respectively), we performed the multi-
ple HE regression
where the subscript 0 denotes a marker for the structural
gene locus and the subscript 1 denotes another locus in
the genome. The coefficient λ denotes the (attenuated)
genetic variance at locus 1 and a value significantly differ-
ent from zero indicates an additive effect of locus 1 with
locus 0 on gene expression level. We further investigated
genetic interaction between the structural gene locus and
the other locus with the model
where γ denotes variance (again, attenuated by recombi-
nation) due to the genetic interaction between locus 1 and
locus 0, and a value significantly different from zero indi-
cates an interactive effect of the two loci on gene expres-
Y i= +β β π0 1 ˆ ,
πˆ i
Y = + +β β π λπ0 1 0 1ˆ ˆ ,
Y = + + +β β π β π γπ π0 1 0 2 1 0 1ˆ ˆ ˆ ˆ ,Page 2 of 5
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program GENIBD. Both of the above programs are
included in the Statistical Analysis for Genetic Epidemiol-
ogy (S.A.G.E.) software [23].
Results
Linkage of COMT expression levels
We detected a linkage signal at chromosome 22q11 (p =
6.5 × 10-3). The closest SNP to the peak of the signal is
rs738842, which is ~3 megabases (Mb) centrometric to
the COMT gene and within the cis-acting region defined
by Morley et al. [15]. There were 10 regions showing only
additive trans-acting effects (Table 1) and 7 regions show-
ing only interactive trans-acting effects (Table 2) at the
nominal significance level of 0.005; at 14 other regions,
both effects attained a nominal significance level of 0.05
and at least one attained the level 0.005 (Table 3). These
nominal significance levels were arbitrarily chosen in
order to report the most notable results. Note that 1) chro-
mosome 9q34, where DBH is located, showed an additive
trans-acting effect with 22q11 on COMT expression level;
and 2) chromosome 20q13, which was one of the two hot
spots of transcriptional regulation detected by Morley et
al. [15], was also detected to have an additive effect with
22q11 on the COMT expression level.
Linkage of DBH expression levels
There was no linkage signal for the DBH expression level
at either chromosome 9q34 or chromosome 19p13 when
analyzing all of the 14 pedigrees together. There could be
many reasons for the lack of any linkage signal at chromo-
some 9q34, the structural gene location (see Discussion).
However, upon analyzing the pedigrees individually, it
was noticed that three pedigrees (1340, 1345 and 1318),
which included 70 full sibling pairs, showed a positive
linkage signal at 9q34. Because our primary interest was to
test whether there is a second locus near chromosome
19p13 related to DBH, in addition to the DBH gene, we
selected these three pedigrees for further study and found
that a linkage signal at 19p13 then also emerged, showing
both additive and interactive trans-acting effects (p = 2.4 ×
10-2 and p = 2.6 × 10-2, respectively) with the locus at chro-
mosome 9q34 on DBH expression level (Fig. 1).
Discussion
Phenotypic variation in the transcript level of a gene
involves genetic components; however, the transcrip-
tional regulatory elements may or may not lie in the struc-
tural gene itself. Studies by Morley et al. [15] have
suggested the existence of master regulatory regions, and
we identified chromosome 20q13, nominated by them,
as regulating COMT expression level. Note that Morley et
al. [15] performed simple HE regression, while we per-
formed multiple HE regression so as to condition on the
Table 2: Chromosome regions showing only interactive trans-acting effectsa with 22q11 on COMT expression level
Genomic region Closest marker Physical distance (Mb) p-Value for γ
1q32 rs871446 196.9 1.9 × 10-3
3p26 rs1385466 4.0 1.2 × 10-5
6q23 rs2040034 137.3 3.9 × 10-4
9q33 rs1326808 116.7 2.1 × 10-3
10q22 rs1907308 78.0 8.3 × 10-6
15q26 rs288423 96.0 3.3 × 10-3
18q21 rs1943985 45.5 1.5 × 10-4
aAt a nominal level of 0.005
Table 1: Chromosome regions showing only additive trans-acting effectsa with 22q11 on COMT expression level
Genomic region Closest marker Physical distance (Mb) p-Value for λ
3q26 rs1499812 173.2 4.4 × 10-3
4q35 rs1979255 190.7 3.4 × 10-4
5q34 rs1387395 163.8 4.1 × 10-3
6p22 rs1475149 21.8 2.5 × 10-3
7p21 rs988418 9.9 3.7 × 10-3
8q22 rs1075394 101.5 1.8 × 10-3
9q34 rs936249 138.2 2.2 × 10-3
10p11 rs1857063 29.4 2.0 × 10-7
18p11 rs321663 8.6 2.1 × 10-4
20q13 rs756529 47.4 3.1 × 10-3
aAt a nominal level of 0.005Page 3 of 5
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inal investigation and provided further evidence support-
ing chromosome 20q13 as a regulatory region. In the
current data, overall there was a linkage signal at 22q11
for COMT expression level, but no signal at 9q34 for DBH
expression level. Lack of an overall linkage signal at 9q34
for DBH could be due to there not being enough DBH
polymorphism segregation in the sample, to there being
less expression variation among individuals than between
replicates within an individuals [15], from low levels of
transcript abundance in view of its tissue-specific expres-
sion pattern (Dr. Joseph F. Cubells, personal communica-
tion), or to genetic heterogeneity, as also indicated in the
earlier study of plasma DBH activity [16].
In this study we employed multiple HE regression to
detect additive and interactive effects between two loci. In
the three pedigrees selected for having a positive linkage
signal at 9q34 for DBH expression level, we detected a
boost of signal at chromosome 19p13, where previous
studies [16-18] indicated the existence of a locus influenc-
ing DBH plasma activity. The multiple HE regression indi-
Linkage signals of DBH expression levels at chromosomes 9q34 and 19p13Figur 1
Linkage signals of DBH expression levels at chromosomes 9q34 and 19p13.
Table 3: Chromosome regions showing both additive and interactive trans-acting effectsa with 22q11 on COMT expression level
p-Value
Genomic region Closest marker Physical distance (Mb) λ γ
1q41 rs1561189 213.5 1.1 × 10-4 4.6 × 10-3
2q35 rs1425118 216.8 <1.0 × 10-8 3.5 × 10-2
3q28 rs1559018 191.8 2.3 × 10-2 2.9 × 10-5
4q31 rs795995 141.1 1.5 × 10-3 5.0 × 10-7
5q14 rs1020720 80.5 1.7 × 10-2 1.8 × 10-3
6q16 rs2021678 102.1 1.1 × 10-3 4.7 × 10-2
7p14 rs2051936 40.8 5.7 × 10-3 3.5 × 10-3
8p23 rs433960 12.9 4.7 × 10-2 2.9 × 10-5
9p23 rs1412307 13.0 1.3 × 10-4 6.6 × 10-3
14q13 rs1983667 36.2 1.4 × 10-4 1.1 × 10-2
16p13 rs1981492 0.3 1.0 × 10-3 5.9 × 10-3
16q24 rs880275 84.8 4.7 × 10-3 2.6 × 10-3
17p12 rs433068 15.2 4.8 × 10-2 4.4 × 10-3
22q13 rs960362 47.4 4.8 × 10-4 8.6 × 10-3
aBoth effects attained a nominal significance level of 0.05 and at least one reached the level 0.005.Page 4 of 5
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suggesting epistasis between them. For simplicity, and
because of the limited amount of data available, we did
not dissect the total genetic variance into additive and
dominance components in this study; with more data the
interaction could be characterized by more elaborate
models [24], and even embedded in a general pedigree
framework [25,26]. We also noticed that chromosome
9q34, where DBH is located, showed an additive trans-act-
ing effect with 22q11 on COMT expression level. This is
not totally unexpected because both enzymes are involved
in catecholamine metabolism; however, we could not
find in the literature any genetic study on the interaction
between them, which is surprising. Interaction between
COMT and DBH could be a potential research topic.
In summary, we performed quantitative linkage analysis
for both COMT and DBH expression phenotypes, identi-
fying transcriptional regulatory regions for both genes.
Multiple HE regression was used to detect additive and
interactive effects between two loci. The master transcrip-
tional regulatory region 20q13 had an additive effect on
the COMT expression level. Chromosome regions 9q34
and 19p13 acted epistatically on DBH expression level.
Potential interaction between COMT and DBH was indi-
cated.
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